Author

Steven E. Nissen

0 works0 citationsORCID

Recent research

  • Health & Medicine

    Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)

    BackgroundPelacarsen, an antisense oligonucleotide, reduces serum levels of lipoprotein(a). However, the effect of pelacarsen on cardiovascular outcomes remains uncertain. MethodsWe conducted an international, randomized, placebo-controlled trial involving patients with preexisti...

    New England Journal of Medicine2026-11-070 citationsDOI
  • Health & MedicineOpen access

    Bariatric Surgery as a Rescue Strategy After Semaglutide or Tirzepatide

    OBJECTIVE: To evaluate 2-year weight loss after bariatric surgery among adults with intolerable adverse effects or inadequate weight loss with semaglutide or tirzepatide. SUMMARY BACKGROUND DATA: Semaglutide and tirzepatide are effective obesity medications, but intolerance and i...

    Annals of Surgery2026-11-030 citationsDOI